3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Liquidia and its subsidiary Liquidia Technologies signed a settlement agreement with United Therapeutics on October 13, 2026, resolving all pending litigation between the companies. Liquidia will keep marketing YUTREPIA for pulmonary arterial hypertension but must remove the PH-ILD indication from the label and stop promoting it for that use, and it must make payments totaling a stated net $380.7 million in 2026 and 2027.
Net payment to United Therapeutics of $175.0 million due within 30 business days, plus $145.4 million in two $72.7 million installments due January 31, 2027 and April 30, 2027
Separate settlements with Sandoz, Henderson and PBM total about $60.3 million; the PBM agreement is with a related party that is controlled by a director, and the board's disinterested members approved it
Lender consent for a letter of credit tied to the settlement raised the minimum cash covenant under the revenue interest financing agreement from $15.0 million to $45.0 million
Preliminary, unaudited third-quarter 2026 YUTREPIA net product sales were $222.7 million, and cash and cash equivalents were $396.1 million as of September 30, 2026
Pioneer Acquisition I Corp, a blank check company listed on Nasdaq, entered into a Business Combination Agreement on October 6, 2026 with Green AI Cloud, Inc., a Stockholm-based AI data center company. If completed, Green AI Cloud would become a wholly owned subsidiary of Pioneer, and its shareholders would receive 30,000,000 shares of Pioneer common stock, plus up to 5,000,000 earn-out shares. The deal requires approval by Pioneer shareholders and is expected to close in the second quarter of 2027.
Green AI Cloud is valued at a pre-money equity value of $300 million; the Aggregate Consideration is 30,000,000 shares at $10.00 per share.
Up to 5,000,000 earn-out shares ($50 million at $10.00 per share) vest in three tranches based on 2027–2029 EBITDA targets or share prices of $11.00–$13.00.
Pioneer will redomicile from the Cayman Islands to Delaware before the merger; the deal is expected to close in the second quarter of 2027.
The agreement has a business combination deadline of June 20, 2027, and Pioneer's public shareholders may elect to have their shares redeemed.
Energy Fuels filed a prospectus supplement that allows it to sell up to an additional $500 million of common shares under its at-the-market program, at its discretion over time. The company previously sold about $300 million of shares under an earlier supplement tied to the same sales agreement, so the new filing adds capacity for future share sales that could dilute existing shareholders.
Up to $500 million of additional common shares may be sold under the at-the-market program.
About $300 million in gross proceeds was raised under the Prior Prospectus Supplement dated June 13, 2025.
The sales agreement with five sales agents is dated June 13, 2025, and the filing references Form S-3 File No. 333-278193.
Dentons LLP provided a legal opinion (Exhibit 5.1) and consent (Exhibit 23.1) for the supplement.
On October 13, 2026, Biomea Fusion reported topline Phase 1 GLP-131 results for BMF-650, its investigational oral GLP-1 receptor agonist. In Cohorts 1-4, mean Day 29 weight reduction ranged from 1.5% to 3.2% versus 0.1% for pooled placebo, and the company reported no severe or serious adverse events among active-dose participants, but the results are preliminary, the sample sizes are small, and the company says longer-term toxicology studies are still needed before further development, which may include a partnership.
Cohorts 1-4 (outpatient): mean Day 29 weight reduction of 1.5% to 3.2% versus 0.1% for pooled placebo.
Cohort 5 (under confinement, 200 mg then 400 mg): 6.1% (6.2 kg) mean weight reduction at Day 29; the company says it should be interpreted separately because confinement appeared to affect eating behavior.
No severe or serious TEAEs, TEAE-related dose modifications, or TEAE-related discontinuations across the 40 active-dose MAD participants; nausea occurred in 17.5% and vomiting in 7.5% across active cohorts.
Longer-term toxicology studies are required; the company is positioning BMF-650 for a strategic partnership, which could include licensing, while its primary focus remains icovamenib.
Sadot Group and VisionWave Holdings terminated the joint venture agreement for CMJV LLC, which was set up to lend to Israeli advanced-composites maker C.M. Composite Materials, effective October 12, 2026. CM told the company on or about October 8, 2026 that it could not produce the financial statements the agreement required, so no funding took place. The company has no further funding obligation and no break fee, and it will receive 500,000 VisionWave common shares, while VisionWave keeps the 250,000 entry premium shares it already held.
Termination Agreement dated October 12, 2026 ends the JV Agreement dated September 30, 2026, which had committed the company to contribute $7,814,323 in cash over twelve months.
The company had funded none of the commitment, and it paid no early termination penalty or break fee.
The company's 7,814,323 CMJV membership units were cancelled for no consideration, and it no longer holds any interest in CMJV or CM.
VisionWave agreed to issue the company 500,000 shares of its common stock, and the company expects them to be restricted securities.
On October 12, 2026, VisionWave agreed with Sadot Group and others to terminate the September 30 joint venture, after CM said it could not produce the financial statements the agreement required. Sadot's funding commitment of up to $7,814,323 was extinguished without any amount being funded, and no termination penalty is payable. VisionWave keeps 250,000 Sadot shares and will issue 500,000 of its own common shares to Sadot, while it also takes on indemnification obligations to Sadot.
Letter Agreement dated October 12, 2026 terminated the JV Agreement signed September 30, 2026 with Sadot Group Inc. and CMJV LLC
Sadot's Capital Commitment of up to $7,814,323 was terminated and none of it was funded; no early termination penalty or break fee is payable
VisionWave will issue 500,000 shares of common stock to Sadot within three business days and retains 250,000 Sadot Entry Premium Shares
VisionWave, VisionWave Israel and CMJV jointly and severally agreed to indemnify Sadot against losses tied to the CM Rights and related matters
Dot Ai (CID HoldCo, Inc.) closed its acquisition of Envoy Technologies, Inc. on October 9, 2026, making Envoy a wholly owned subsidiary. The deal was paid in Dot Ai common stock and Series C Preferred Stock, valued at about $65.0 million at a $6.00 reference price, and it is expected to leave BladeRanger holding a majority of Dot Ai's common stock on an as-converted basis once conversions are completed, which would dilute existing shareholders. The company believes it now meets Nasdaq's $2.5 million stockholders' equity requirement, but its continued listing remains subject to the Nasdaq Hearings Panel's confirmation.
Closed October 9, 2026; BladeRanger received 233,543 common shares and 8,433,123 Series C Preferred Shares at closing
Blink Charging holds a $12,500,000 Envoy convertible note that will convert into 2,166,667 common shares upon stockholder approval and an effective Form S-1 registration statement
Dot Ai believes its stockholders' equity meets the $2.5 million Nasdaq minimum; the Nasdaq Hearings Panel must confirm
Parties agreed to use reasonable best efforts to obtain stockholder approval by January 31, 2027
Calisa Acquisition Corp amended and restated its Prepaid Forward Purchase Agreement with Goodvision AI and Harraden Circle Investments on October 13, 2026, to maximize the funds the company retains after its business combination with Goodvision. The Purchaser may buy up to 3,000,000 Ordinary Shares from public holders at no more than about $10.31 per share, which shareholders who sell to the Purchaser would receive, and the Company would pay the Purchaser from trust funds after closing.
Purchaser may buy up to 3,000,000 Ordinary Shares at no more than the redemption price, about $10.31 per share
Prepayment is due by the earlier of one business day after closing or the date trust assets are disbursed
Unsold shares return to the Company at a maturity date 15 months after closing
Nasdaq's Hearings Panel decided on October 7, 2026, that CN Healthy Food Tech Group is in compliance and may remain listed, subject to conditions. The panel found the company failed to give Nasdaq and investors accurate information about its China Securities Regulatory Commission application, though it said the omission did not relate to finances or business operations.
Panel decision dated October 7, 2026; company may remain listed on Nasdaq
Company must keep remedial measures for three years from the panel decision date
One-year Discretionary Panel Monitor: any listing standard failure leads to a Staff Delisting Determination without a cure period
Company does not intend to seek Listing Council review; the council may still review on its own within 45 days
Sizzle Acquisition Corp. II filed an investor presentation from Trasteel Holding S.A. under Item 7.01, furnished as Exhibit 99.1, for the business combination agreed on April 13, 2026. The presentation shows Trasteel's unaudited, preliminary first-half 2026 revenue, gross profit and EBITDA rising sharply from the prior-year period. The figures are management IFRS numbers and are subject to change, and the deal remains pending.
H1 2026 total revenues of $1,192.4 million, up 40.0% from $851.8 million in H1 2025
H1 2026 gross profit of $105.9 million, up 36.9% from $77.4 million
H1 2026 EBITDA of $50.7 million, up 80.8% from $28.0 million, per unaudited IFRS management figures
Polar Power's board approved a co-CEO structure under which Chris Mayer became Co-Chief Executive Officer effective October 6, 2026, while Arthur Sams continues as Co-CEO and President. Mayer will oversee corporate strategy, financial performance, investor relations and capital allocation, and Sams will oversee operations, and Mayer is also the managing member of CL Investment, an investor that holds the Company's securities and has a board designee.
Chris Mayer, age 30, appointed Co-CEO effective October 6, 2026, with no compensatory arrangement disclosed for his appointment.
Arthur Sams remains Co-CEO and President; his compensation will not change under the new structure.
Mayer controls CL Investment, which bought 833 Series A Convertible Preferred shares and warrants for 227,182 common shares on August 5, 2026, and a $82,500 convertible note for $75,000 on August 28, 2026.
The Company announced the structure in a press release dated October 12, 2026, citing growth opportunities in telecom, data centers and defense.
Tessera Defense & Homeland Security disclosed it has raised more than $6 million in net proceeds through its at-the-market stock offering through October 12, 2026, at an average net price of about $1.11 per share, adjusted for a one-for-ten reverse stock split effective September 9, 2026. Management said it may temporarily halt sales under the program based on its ongoing review of capital needs and market conditions.
Net proceeds above $6 million raised through the at-the-market offering through October 12, 2026
Average net price of approximately $1.11 per share, adjusted for the one-for-ten reverse split effective September 9, 2026
Management may temporarily halt sales under the program when it deems appropriate
On October 13, 2026, Energy Fuels and the parties to the VAC acquisition merger agreement signed a First Amendment that addresses an ongoing customer dispute over a commercial supply agreement, possible settlement, repayment of certain debt, and possible purchase price adjustments. The 8-K also includes VAC's 2025 audited financial statements, which show lower revenue and continued losses, and discloses the planned departure of Energy Fuels' Chief Legal Officer.
Merger Agreement Amendment dated October 13, 2026 covers a customer dispute, possible settlement, debt repayment and potential purchase price adjustments.
VAC (Ara VAC IE Aggregator, LP) revenue was EUR 325.1 million in 2025, down from EUR 353.5 million in 2024.
VAC reported a loss after tax of EUR 87.9 million in 2025, compared with a loss of EUR 96.8 million in 2024.
Energy Fuels disclosed the planned departure of its Chief Legal Officer and Executive Vice President, Global Government Relations; the filing does not name the executive.
The SEC declared effective the Form S-4 registration statement for the proposed business combination between Agility Robotics and Churchill Capital Corp XI (Nasdaq: CCXI) on October 13, 2026. Churchill XI has set an extraordinary general meeting of shareholders for November 2, 2026 to vote on the deal, which is expected to close in November 2026 and would list the combined company on Nasdaq as AGLT.
SEC declared the S-4 registration statement effective on October 13, 2026; it was originally filed September 4, 2026.
Churchill XI shareholder meeting set for November 2, 2026 at 9:00 a.m. Eastern Time.
Expected gross proceeds above $620 million, including about $424 million in trust (assuming no redemptions) and about $200 million from a PIPE led by Foxconn.
Closing expected in November 2026; the combined company would trade as AGLT.
Copley Acquisition Corp and Ignite Proteomics mutually agreed on October 9, 2026 to terminate their June 10, 2026 Business Combination Agreement. Copley says it intends to keep pursuing a business combination and has until November 2, 2026 to complete one, subject to extension under its organizational documents.
Business Combination Agreement with Ignite Proteomics, signed June 10, 2026, was terminated by mutual agreement on October 9, 2026.
Each party bears its own expenses, and the agreement includes mutual releases of claims tied to the terminated deal.
Copley's deadline to complete a business combination is November 2, 2026, subject to extension.
Filing warns Copley may have to redeem public shares and liquidate its trust account if it cannot complete another deal.
Porch Group and Porch Insurance Reciprocal Exchange agreed on October 13, 2026 to acquire Allied Trust's insurance carrier and managing general agency, with the carrier purchase at a $55 million cash base price plus $50 million of deferred consideration. The company expects the deal to add approximately $200 million of Reciprocal Written Premium and $25 million of Adjusted EBITDA (Excluding Reciprocal) in the first full year after closing, but the transaction requires regulatory approvals and is expected to close in the first quarter of 2027.
Carrier purchase: $55 million in cash base price, plus $50 million deferred consideration payable over the 12 months after closing in cash or PRCH shares
Managing general agency and captive reinsurance entity: $95 million aggregate base price, including $75 million in cash and an expected $20 million in PRCH shares
Expected first-full-year contribution: approximately $200 million Reciprocal Written Premium and $25 million Adjusted EBITDA (Excluding Reciprocal); Porch cites an acquisition multiple of less than four times
Closing expected in Q1 2027, subject to regulatory approvals including Texas Department of Insurance; Porch plans to file an at-the-market equity offering program
Brightline Interactive disclosed that director Brian Archer, chair of the Audit Committee, will resign effective at the 2026 annual meeting of shareholders, and that the board plans to name a successor by its first meeting after that meeting. The filing also discloses that CFO William Keneally is provided through a consulting agreement with CXO Partners at $15,000 per month, which is a structure the company says is not a standard employee benefit arrangement.
Brian Archer tendered his resignation on October 6, 2026; he stays on the board until the 2026 annual meeting and says the decision was not tied to any disagreement with the company.
The company's CFO, William Keneally, is serving through a consulting agreement with CXO Partners dated October 9, 2026, at a monthly fee of $15,000, effective June 16, 2026 through February 15, 2027.
Director Pete Fesler was moved from Class I to Class III, with his term now expiring at the 2026 annual meeting, as part of a board reclassification effective October 13, 2026.
Equus Total Return, Inc. was notified by the NYSE on October 6, 2026, that its common stock fell below the $1.00 minimum average closing price over 30 consecutive trading days. The notice is a deficiency notice, not a delisting, and the stock continues to trade on the NYSE for now. Shareholders should note the company plans to cure the deficiency within a six-month period, with a reverse stock split among the options it is considering.
NYSE notice dated October 6, 2026 cites Section 802.01C: average closing price below $1.00 over 30 consecutive trading days
Company plans to notify the NYSE by October 20, 2026 of its intent to cure the deficiency
Cure period is six months from receipt of the notice; a reverse stock split is among the alternatives under consideration
Common stock continues to trade on the NYSE; the company said the notice does not affect its operations or SEC reporting
Minerals Technologies completed a $400 million offering of 7.500% Senior Notes due 2032 and amended its credit agreement with JPMorgan Chase Bank as administrative agent. The company plans to use the note proceeds, plus cash on hand, to redeem its outstanding 5.000% senior notes due 2028 and pay offering fees. The amendment replaces the existing $400 million revolving facility with a $500 million facility maturing October 13, 2031.
$400 million of 7.500% Senior Notes due 2032, interest payable January 15 and July 15 starting January 15, 2027
Proceeds, with cash on hand, to redeem all outstanding 5.000% senior notes due 2028 and pay fees
New $500 million senior secured revolving credit facility maturing October 13, 2031, replacing the $400 million revolver
Existing $564.9 million senior secured term loan facility is not changed and matures November 26, 2031
Park Dental Partners disclosed that unauthorized access to its network in August 2026 led to data being acquired, including patients' protected health information, and it is completing notifications under state and federal law. Four putative class actions have been filed in Minnesota state court, and the company says it has not identified any material impact on its financial condition or results to date.
Unauthorized network access identified on August 28, 2026; law enforcement notified
Four putative class actions filed in Ramsey County, Minnesota; first filed September 3, 2026
Plaintiffs moved on October 7, 2026 to consolidate the actions and appoint interim lead class counsel
No material impact on financial condition or results identified to date, including expected legal and advisor costs
Illumina entered into dealer agreements on October 8, 2026, to establish an unsecured commercial paper program allowing short-term notes of up to $1.0 billion outstanding at any time. The company said no notes were outstanding as of the filing date and proceeds are expected to fund general corporate purposes, so the program adds borrowing capacity rather than existing debt.
Program caps outstanding CP Notes at $1.0 billion; no notes were outstanding as of the filing date
Maturities may not exceed 397 days from the date of issue
Three commercial paper dealers and a national bank as issuing and paying agent
Proceeds expected for general corporate purposes; dealer agreement form filed as Exhibit 10.1
Consumer Portfolio Services amended its revolving warehouse credit agreement on October 9, 2026, raising the maximum amount outstanding at any time from $390 million to $518 million. The company says the larger facility supports growth in its auto lending programs and that total credit capacity across its facilities is now $1.026 billion, the first time it has exceeded $1 billion.
Maximum outstanding capacity increased from $390 million to $518 million under the amended Credit Agreement with Capital One, N.A. and a Class B Lender
Total credit capacity across CPS facilities is $1.026 billion
Revolving borrowing available through October 17, 2027, followed by an option to repay in full or amortize over eighteen months
Loans bear interest at a floating rate set as a margin above the secured overnight financing rate and are secured by auto receivables
On October 13, 2026, Tenable Holdings entered into a $400.0 million senior secured revolving credit agreement with JPMorgan Chase Bank, N.A. as administrative agent. The company had no outstanding revolving loans at signing, and the press release says the facility completes the refinancing of its prior credit agreement along with the convertible note financing announced in September.
Facility size is $400.0 million, including a $40.0 million sublimit for letters of credit; about $200,000 of letters of credit were outstanding at signing and no revolving loans were drawn.
Revolving loans mature on October 13, 2031, subject to a springing maturity tied to other material debt.
Financial covenants require a Total Leverage Ratio of no more than 4.00:1.00 and an Interest Coverage Ratio of at least 3.00:1.00, tested quarterly.
Obligations are secured by substantially all company and subsidiary guarantor assets; the company pays a quarterly commitment fee of 0.175% to 0.35% on unused availability.
Vulcan Infrastructure and Power Inc. completed the redemption of all $30,345,200 of its 8.50% Senior Notes due 2026 at 100% of principal plus accrued interest, for a total payment of about $30.9 million. The company said the notes will be delisted from Nasdaq and deregistered, and its Class A common stock (VIP) is unaffected. As of September 30, 2026, preliminary unaudited cash and digital assets were $16.9 million after the redemption and about $1.4 million of remaining PIPE-related expenses.
Redeemed $30,345,200 aggregate principal of 8.50% Senior Notes due 2026; no notes remain outstanding
Total payment of about $30.9 million, including about $523,000 of accrued interest through October 12, 2026
Notes ceased trading on Nasdaq at the close on October 12, 2026; delisting expected about October 23, 2026
Preliminary unaudited cash and digital assets of $16.9 million as of September 30, 2026
MasterCraft filed unaudited pro forma combined results for the fiscal year ended June 30, 2026, showing how its May 15, 2026 acquisition of Marine Products Corporation would have looked had it closed July 1, 2025. The pro forma loss from continuing operations is $10.0 million, or $0.40 per share, compared with MasterCraft's historical loss of $1.6 million, or $0.09 per share. The filing is supplemental and does not report actual combined results.
Pro forma net sales of $565.8 million, versus MasterCraft historical net sales of $348.9 million
Pro forma loss from continuing operations of $10.0 million, or $0.40 per share, on 25,251,021 weighted average shares
Total merger consideration of $284.2 million: $199.4 million in stock (8,088,171 shares) and $84.8 million in cash
Preliminary purchase price allocation; the company says final amounts may differ materially and that the figures exclude synergies and integration costs
Offerpad's wholly owned subsidiary OP SPE Summit, LLC signed an amended revolving loan agreement dated October 7, 2026, increasing the uncommitted borrowing capacity from $150 million to $200 million. The filing describes customary covenants and default terms, including a financial covenant that restricts the subsidiary's ability to incur indebtedness.
Uncommitted borrowing capacity rises from $150 million to $200 million under the Third Amended and Restated Revolving Loan Agreement, dated October 7, 2026.
The agreement amends and restates the Second Amended and Restated Revolving Loan Agreement dated July 29, 2026.
Lenders are WHGG II Trust and Ascent Developer Solutions LLC; the agreement includes customary events of default that permit acceleration of outstanding borrowings.
After the FDA approved RASONQUE (daraxonrasib) for metastatic pancreatic adenocarcinoma, Revolution Medicines borrowed a $250.0 million Tranche A loan from Royalty Pharma under a senior secured facility. The company also chose not to sell a Tranche 3 revenue participation right, which would have brought in up to $250.0 million, so it will not receive that payment.
Tranche A loan of $250.0 million advanced on October 8, 2026, with a $5.0 million draw fee paid to the lender.
Interest is three-month Term SOFR (3.50% floor) plus 5.75%, paid quarterly; the loan is interest-only and matures October 8, 2032.
Prepayment carries a make-whole amount plus a 3.0% premium before October 8, 2028, and smaller premiums afterward.
The company did not deliver a Tranche 3 Notice by October 10, 2026, forgoing a Tranche 3 Purchase Price of up to $250.0 million.
On October 6, 2026, Third Coast Bancshares entered into an agreement to acquire Great Plains Bancshares, parent of Great Plains National Bank in Elk City, Oklahoma, through a two-step merger in which Great Plains shares convert into Third Coast common stock. The deal requires approval from shareholders of both companies, regulatory approvals and the effectiveness of a Form S-4, and it would increase the number of Third Coast shares outstanding.
Agreement dated October 6, 2026; Great Plains shareholders holding about 27.6% of Great Plains stock signed a voting agreement to support the merger.
Exchange ratio equals 5,570,352 divided by Great Plains shares outstanding at closing, and is reduced if Great Plains delivers less than $153,300,000 of adjusted capital, surplus and retained earnings.
Great Plains would pay a termination fee of $11,981,827 in certain circumstances, including those involving alternative acquisition proposals.
Either party may terminate if the merger is not completed by September 30, 2027; the Company is to add two directors, Todd Taylor and Paul M. Dickinson, to its board at closing.
STERIS, through subsidiary STERIS Corporation, agreed on October 11, 2026 to acquire Xodus Medical, a Pennsylvania specialty surgical products business, for $2.1 billion in cash at closing, with up to $150 million more tied to calendar 2028 performance targets. The deal is expected to be financed mainly with debt, backed by a $2.0 billion bridge financing commitment, and is expected to close by December 31, 2026, subject to regulatory approvals.
Cash price: $2.1 billion at closing, subject to customary adjustments, plus up to $150 million in earnout tied to calendar 2028 targets
Financing: expected to be funded primarily with debt; $2.0 billion senior unsecured bridge facility from JPMorgan Chase Bank and Goldman Sachs Bank USA
Timing: expected to close by December 31, 2026; either party may terminate if not closed by July 12, 2027, extendable to January 11, 2028
Universal Corporation entered into Amendment No. 1 to its Credit Agreement with JPMorgan Chase Bank, N.A. on October 9, 2026, temporarily raising the maximum Total Net Leverage Ratio it must maintain. The covenant rises from 3.00 to 1.00 to 3.75 to 1.00 for the quarters ending September 30 and December 31, 2026, then steps down to 3.25 to 1.00 for March 31, 2027 before returning to 3.00 to 1.00 from June 30, 2027.
Maximum Total Net Leverage Ratio set at 3.75 to 1.00 for quarters ending September 30, 2026 and December 31, 2026
Covenant steps down to 3.25 to 1.00 for quarter ending March 31, 2027
Covenant returns to 3.00 to 1.00 for quarter ending June 30, 2027 and later quarters
Filing describes other amendments as non-material; all other credit agreement terms unchanged
On October 13, 2026, Enova International's subsidiary NetCredit Receivables 2022, LLC entered into a Fourth Amendment to its Note Issuance and Purchase Agreement with Jefferies Funding LLC and others. The amended facility has a $200 million commitment amount, priced at SOFR plus 4.00%, and a maturity date of October 15, 2030, which sets the financing terms for the subsidiary's borrowing capacity.
Commitment amount under the amended agreement is $200,000,000.
Borrowing rate is SOFR plus 4.00%; funding rate is 90%.
Revolving period terminates October 15, 2028; maturity date is October 15, 2030.
Jefferies Funding LLC is administrative agent; Citibank, N.A. is collateral agent and paying agent.
AZZ reported second-quarter fiscal 2027 sales of $486.9 million, up 16.7%, and adjusted diluted EPS of $2.00, up 29.0%, for the quarter ended August 31, 2026. GAAP diluted EPS fell 34.2% to $1.94 because the prior-year quarter included a large AVAIL joint venture gain, and the company raised its fiscal 2027 guidance for sales, adjusted EBITDA and adjusted diluted EPS.
Second-quarter sales were $486.9 million; Metal Coatings rose 22.9% to $233.5 million and Precoat Metals rose 11.5% to $253.4 million.
GAAP diluted EPS was $1.94, down 34.2%; adjusted diluted EPS was $2.00, up 29.0%.
Fiscal 2027 adjusted diluted EPS guidance was raised to $7.00-$7.30 from $6.75-$7.15, and sales guidance to $1.825-$1.875 billion from $1.80-$1.85 billion.
During the first half, AZZ repurchased $20.0 million of common stock and completed the $57.5 million Seattle Galvanizing acquisition.
Better Home & Finance Holding Company reported preliminary third-quarter 2026 Loan Volume of $1.39 billion, up 15% from a year earlier and toward the lower end of its prior guidance range of $1.375 billion to $1.525 billion. The company also reported Tinman AI platform volume of $790 million, up 64%, and said it has implemented about $13.2 million in annualized expense reductions, with a further $51 million targeted. The results are preliminary, the company did not report profit or earnings per share in this filing, and the figures remain subject to its closing procedures.
Total Loan Volume of $1.39 billion, up 15% from $1.21 billion in Q3 2025, within guidance of $1.375 billion to $1.525 billion
Tinman AI platform volume of $790 million, up 64% from $483 million, about 57% of total Loan Volume
About $13.2 million in annualized expense reductions implemented; $64.2 million annualized targeted once fully implemented
Results are preliminary estimates subject to completion of closing procedures; the company is in a 2-month public proxy fight
Arrive AI announced on October 12, 2026 the formation of Arrive AI Defense, a new division to bring its autonomous delivery infrastructure to defense, military, diplomatic and national security customers. Chief Strategy Officer Neerav Shah will lead the division, and the company says it may pursue non-dilutive government funding. The filing states no government funding awards or defense contracts have been announced, so the division has no disclosed financial impact yet.
Arrive AI Defense announced October 12, 2026; Neerav Shah, Chief Strategy Officer, will lead it
Planned applications include battlefield resupply, U.S. embassy Arrive Points and military medical logistics
Company intends to evaluate SBIR and STTR programs and other government funding, with no awards announced
Filing states there can be no assurance the company will qualify for or receive such funding
On September 30, 2026, Interactive Strength exchanged $7,685,090 of outstanding convertible note obligations for 768,509 shares of newly designated Series R Convertible Preferred Stock, and the notes were cancelled. On October 1, 2026, subsidiary Wattbike refinanced its working capital facility with up to £1,375,000 (about $1,825,200) of new term, invoice discounting and inventory financing, with lenders holding security over its assets. The Series R preferred ranks senior to common stock and is convertible into common, and the new loans include events of default that allow lenders to demand immediate repayment.
September 30, 2026: $7,685,090 of remainder notes exchanged for 768,509 Series R Preferred shares; company to reimburse holders $50,000 in legal fees
October 1, 2026: Wattbike prior facility repaid in full, with a £85,000 (about $112,800) exit fee and new financing of up to £1,375,000 (about $1,825,200)
Inventory loan facility of up to £750,000 (about $995,600) carries interest of 1.85% per month and is secured by a debenture over all Wattbike assets
Series R Preferred ranks senior to common stock; 1,619,907 common shares were outstanding as of September 30, 2026
McEwen and two subsidiaries agreed to sell their Fuller and Paymaster properties and a surface rights parcel in Timmins, Ontario, to Dome Mine Ltd., a unit of Discovery Mining Ltd., for total consideration of $55 million. The company also received $13.5 million from assigning a loan receivable from McEwen Copper Inc. to new third-party lenders, which it says adds to its capital for growth spending.
Purchase price is $55 million: $5 million in cash and $50 million in Discovery Mining Ltd. common shares
Discovery shares will be valued using a five-day VWAP on the TSX ending two business days before closing, and are subject to a four-month-and-one-day hold
Closing is expected after customary conditions are met, including TSX approval for the issuance of the Discovery shares
Company says the two transactions provide approximately $68.5 million of additional capital, including the $13.5 million loan assignment
SAIC said Kenneth Crews, former Corporate Vice President and CFO of Northrop Grumman, will become Executive Vice President and Chief Financial Officer effective December 7, 2026, after joining as CFO-elect on October 30, 2026. Prabu Natarajan, the current CFO, will become permanent Executive Vice President of the Civilian Business Group and will cease being CFO as of the effective date.
Kenneth (Ken) Crews, age 45, joins October 30, 2026 as CFO-elect and assumes the CFO role December 7, 2026
Crews' annual base salary is $740,000, with a short-term incentive cash bonus target of 100% of base salary
Crews receives a one-time sign-on cash payment of $250,000 and a sign-on RSU award with a $2,000,000 grant date value
Prabu Natarajan becomes permanent Executive Vice President, Civilian Business Group, and continues as Executive Vice President of Enterprise Operations
Flyte Aviation furnished a press release reporting preliminary, unaudited third-quarter 2026 revenue of about $2.15 million, up about 110% from $1.02 million in the second quarter. The filing says the auditor has not finished its review, and final results in the Form 10-Q may differ. The filing does not report profit, earnings per share, or guidance.
Preliminary Q3 2026 revenue of about $2.15 million, compared with $1.02 million in Q2 2026
Aviation segment revenue rose 150% sequentially to about $1.87 million; MedTech revenue rose 4% sequentially to about $280,000
Registered platform users exceed 20,000 after more than 13,000 new accounts since the late May 2026 redesign
Results are unaudited and may change once the independent auditor completes its review and the 10-Q is filed
Weave Communications agreed on August 18, 2026 to be acquired by Willow Parent, LLC, an affiliate of Francisco Partners, and this 8-K adds supplemental disclosures to the merger proxy statement. Two shareholder complaints filed September 29, 2026 in New York state court, plus 13 demand letters, allege the proxy statement is misleading; the company denies the claims. The company says the supplemental disclosures do not change the merger consideration or the timing of the October 22, 2026 stockholder vote.
Virtual special meeting to vote on the merger is set for October 22, 2026, at 10:00 a.m. Eastern Time.
Two complaints were filed on September 29, 2026 in the Supreme Court of the State of New York, County of New York; the company has also received 13 demand letters.
The company's board still recommends voting FOR the merger agreement; Jefferies' analysis cites last-twelve-months revenue of $257.8 million as of June 30, 2026 and implied values of $6.60 to $9.51 per share.
Medalist Diversified's operating partnership agreed to guaranties and an environmental indemnity tied to a $13.8 million construction loan for a Savannah, Georgia townhome project held by the company's Mira joint venture. The company also signed a contribution agreement that governs how losses under those guaranties are shared with co-guarantor Spandrel Sponsors Fund II, LP, which bears a completion guaranty for cost overruns.
Construction loan maximum of $13,800,000 from GLP 2505 LLC, dated October 9, 2026, maturing October 9, 2027
Variable rate of the greater of 11.5% or Wall Street Journal Prime plus 4.75%, with minimum aggregate interest of $940,000
Operating partnership provides non-recourse, completion and environmental guaranties; losses shared with co-guarantor by pro rata share unless caused by fault of a party
Quantumsphere Acquisition Corp (QUMS), a special purpose acquisition company, entered into a merger agreement on October 9, 2026 with Fortune Favor Technology Inc., a provider of technology consulting and solutions for medical cold-chain transportation. The deal implies a pre-money equity value of about $600 million for Fortune Favor, and completion depends on shareholder approvals, an SEC registration statement and Nasdaq listing approval.
Agreement signed October 9, 2026; each Fortune Favor share is valued at $10.00 in Purchaser ordinary shares, based on a pre-money equity valuation of about $600 million
Each Quantumsphere ordinary share converts into one Purchaser ordinary share; each right converts into one-seventh of a Purchaser ordinary share
Sponsor Whiteowl Holdings LLC and certain Fortune Favor shareholders agreed to support support agreements; lock-up lasts 180 days after closing or until shares close at or above $12.50 for 20 of 30 trading days
Either party may terminate if the other causes a delay exceeding six months; a $500,000 break-up fee applies in certain cases
B&G Foods said on October 13, 2026, that it has sold its B&M baked beans and brown bread brand and its Joan of Arc canned beans brand to McCall Farms, Inc. The company said it plans to use the net proceeds to repay long-term debt, and the filing does not disclose the sale price or terms, so shareholders cannot yet judge the financial effect.
B&G Foods sold the B&M brand of baked beans and brown bread and the Joan of Arc brand of kidney, chili and other canned beans to McCall Farms, Inc.
The announcement was made on October 13, 2026, in a press release furnished as Exhibit 99.1.
The terms of the transaction were not disclosed.
The company intends to use the net proceeds to repay long-term debt; CEO Robert D. Mills described the sale as a step to simplify the portfolio and reduce leverage.
Senti Biosciences adjourned its virtual 2026 Annual Meeting of Stockholders on October 8, 2026 without conducting any business, though a quorum was present. The company said it needs more time to solicit stockholder votes in favor of the Merger Agreement Proposal, and the meeting will reconvene on October 15, 2026. For shareholders, the vote on the proposed merger remains open, and no changes were made to the proposals.
Annual Meeting convened October 8, 2026 and adjourned without conducting business; a quorum was present
Meeting reconvenes Thursday, October 15, 2026 at 8:00 a.m. Pacific time, virtually
Company is seeking more votes in favor of the Merger Agreement Proposal; polls remain open and no proposals changed
Record date remains September 23, 2026; stockholders who already voted need not act
Niki BioSolutions appointed Thomas Freeburg as its Chief Financial Officer under an employment agreement, with the appointment effective September 1, 2026, for a two-year term that either party can end on 45 days' notice. The filing says his base salary is $250,000, with $25,000 of each monthly payment deferred until the company receives certain funding, and he is eligible for an annual bonus of up to 50% of base salary plus 50,000 stock options at $8.83 per share.
Board appointed Thomas Freeburg as CFO on October 9, 2026, effective as of September 1, 2026
Base salary of $250,000, rising to $275,000 upon receipt of additional company funding
Eligible for an annual bonus of up to 50% of base salary and 50,000 stock options priced at $8.83 per share
Freeburg previously served as CFO of Interpace Biosciences, Inc. from February 2021 through March 2023
The closed-end fund said it will start a share repurchase program that buys back shares when they trade at a discount to net asset value, and raised its regular monthly distribution to $0.1150 per share for October, November and December 2026. The fund also entered a Measurement Period that could allow its term to be continued for up to three more years if performance criteria are met, with no assurance that will happen.
Share repurchases are expected to start after an initial 30-day cooling-off period; Clear Street is the executing broker.
Monthly distribution increased to $0.1150 per share for October, November and December 2026.
Current term expires March 31, 2027, unless extended; the board may extend it for up to one year.
Distributions may be paid partly from sources other than net investment income; final tax character will be known after the fiscal year ends March 31, 2027.
Wheeler Real Estate Investment Trust entered into a Note Purchase Agreement on October 13, 2026, to issue promissory notes totaling up to $25 million in principal, with the initial note at $1 million. The notes carry 0.00% interest, mature 18 months after issuance, and require amortization payments that can be made in common stock, which could dilute existing shareholders, subject to stockholder approval and an effective registration statement.
Initial Note Investor purchase: $1,000,000 principal note; maximum aggregate principal of up to $25,000,000 across Notes.
Notes bear 0.00% interest and mature 18 months after issuance; amortization payment set at 0.4% of original principal per trading day, adjustable between 0.2% and 0.6%.
Amortization payments are paid in common stock at market value, or in cash if the price is below $0.25 per share or other listed conditions are not met.
Closing requires stockholder approval for issuance above 19.99% of outstanding common stock and an effective resale registration statement; purchase price is paid in Series D Preferred Stock at $25.00 liquidation preference.
Citigroup reported third-quarter 2026 net income of $5.2 billion, or $2.85 per diluted share, on revenues of $23.8 billion, up from $3.8 billion, or $1.86 per share, a year earlier. The prior-year figures included a $726 million goodwill impairment tied to the Banamex stake sale, so excluding that item, earnings per share rose 27%. Returns to common shareholders totaled $4.1 billion in the quarter, and management said it expects to exceed this year's return target.
Revenues rose 8% to $23.8 billion, driven by Services, Wealth, Markets and Banking, partly offset by All Other.
Reported EPS of $2.85 compared with $1.86 a year earlier; excluding the prior-year notable item, prior-year EPS was $2.24.
Provision for credit losses was $2.6 billion, up 6%, with a net reserve build of $369 million.
Common Equity Tier 1 capital ratio was 12.8%, unchanged from the prior quarter; return on average tangible common equity was 11.5%.
Alaunos Therapeutics completed its merger with privately held Velaris Therapeutics on October 13, 2026, making Velaris a wholly owned subsidiary. A concurrent $350 million private placement is expected to close on October 14, 2026, and the filing says Velaris holders and the investors will receive large amounts of convertible preferred stock, which can convert into common shares and would dilute existing stockholders once converted.
Velaris holders received 105,286 Series B and 33,054 Series C non-voting convertible preferred shares, each convertible into 1,000 common shares, subject to conditions.
Private placement covers 687,789 common shares at $1.4357 per share and 243,063 Series C preferred shares at $1,435.70 per share, for an aggregate purchase price of approximately $350 million.
Stockholder meeting proposals include conversion approval, an authorized share increase, a name change to Velaris Therapeutics, a reverse stock split and a new equity plan; three directors are to resign upon conversion approval.
SSR Mining agreed on October 13, 2026 to acquire all outstanding shares of Roxmore Resources through a British Columbia plan of arrangement, paying C$6.75 per share in cash. The company said the cash component is funded from its current balance sheet and estimated the fully diluted equity value at about $464 million, with enterprise value of $392 million, excluding the value of a new spin-off company. The deal adds Roxmore's Converse gold project in Nevada, six kilometers from SSR's Marigold mine, which the company says could add about 150,000 to 170,000 ounces of annual gold production with initial capital of $800 million to $900 million.
Cash consideration of C$6.75 per Roxmore common share; estimated fully diluted equity value of about $464 million and enterprise value of $392 million, excluding SpinCo
Closing requires approval by at least 66 2/3% of votes cast by Roxmore securityholders, and the Supreme Court of British Columbia; the company expects completion in Q4 2026
Either party may terminate if closing has not occurred by April 13, 2027; Roxmore would owe a C$18.0 million termination fee in certain circumstances
Roxmore securityholders with about 26.8% of shares have agreed to vote in favor; SSR Mining will hold a 14.99% stake in SpinCo, which will receive US$10.0 million in funding
SS Innovations said it submitted its response to an FDA request for additional information on its 510(k) application for the SSi Mantra surgical robotic system on October 5, 2026. The response includes final data from an expanded human clinical and human factors validation study and a bridging study, and the company expects the FDA to complete its review in the first quarter of 2027. The filing describes a regulatory milestone toward U.S. market entry but gives no financial results or timing guarantees.
Response to the FDA's request for additional information was submitted on October 5, 2026.
The response includes final data from an expanded human clinical and human factors validation study and a bridging study completed in August 2026 at Hospital Internacional de Colombia in Bucaramanga.
The company expects the FDA to complete its review of the response and the 510(k) submission in the first quarter of 2027.
The 510(k) submission covers the initial indication of cholecystectomy (gallbladder removal).
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.